Table 2 Clinical and laboratory findings in the 2000–2004 group and the 2010–2014 group (n = 615)
From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
2000–2004 (n = 284) | 2010–2014 (n = 331) | P | |
|---|---|---|---|
Age (month) | 30.5 ± 22.3 | 29.1 ± 20.5 | 0.433 |
Sex (M/F) | 168/116 | 207/124 | 0.408 |
Fever (day) | |||
Preadmission | 4.9 ± 2.1 | 4.2 ± 1.5 | < 0.001 |
Total | 7.2 ± 3.2 | 6.4 ± 2.0 | < 0.001 |
Hospitalization (d) | 8.5 ± 4.1 | 6.1 ± 2.4 | < 0.001 |
Incomplete KD, n (%) | 75 (26.4) | 153 (46.2) | < 0.001 |
Repeated IVIG, n (%) | 26 (9.2) | 33 (10) | 0.784 |
CALs, n (%) | 67 (23.6) | 52 (15.7) | 0.014 |
Ectasia | 61 (21.5) | 50 (15.1) | 0.046 |
Aneurysm | 6 (2.1) | 2 (0.6) | 0.153 |
WBC (/mm3) | 15,200 ± 5100 | 14,900 ± 5200 | 0.476 |
Neutrophil (%) | 63.4 ± 16.5 | 65 ± 14.8 | 0.226 |
Lymphocyte (%) | 23.4 ± 13 | 24.7 ± 12.2 | 0.197 |
Hemoglobin (g/dL) | 10.8 ± 0.9 | 11.5 ± 0.9 | < 0.001 |
Platelet (/mm3) | 318 ± 159 | 336 ± 98 | 0.012 |
Platelet, follow-up | 513 ± 207 | 431 ± 155 | < 0.001 |
CRP (mg/dL) | 10.4 ± 6.8 | 8.8 ± 5.3 | 0.002 |
ESR (mm/h) | 57 ± 23 | 74 ± 32 | < 0.001 |
Total protein (g/dL) | 6.5 ± 0.7 | 6.5 ± 0.6 | 0.368 |
Albumin (g/dL) | 3.5 ± 0.4 | 3.8 ± 0.5 | < 0.001 |
AST (IU/L) | 77 ± 145 | 62 ± 75 | 0.128 |
ALT (IU/L) | 111 ± 146 | 118 ± 174 | 0.625 |
ALT <40 IU, n (%) | 131 (46.2) | 156 (47.1) | 0.654 |
ALT 41–99 IU, n (%) | 63 (22.2) | 68 (20.5) | 0.684 |
ALT >100 IU, n (%) | 90 (31.6) | 107 (32.3) | 0.863 |